3,5-dihydroxyphenylglycine has been researched along with corticosterone in 2 studies
Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
---|---|---|---|---|---|
301 | 1 | 61 | 27,121 | 124 | 6,622 |
22 | 0 | 10 | 27,121 | 124 | 6,622 |
Protein | Taxonomy | 3,5-dihydroxyphenylglycine (IC50) | corticosterone (IC50) |
---|---|---|---|
Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chamberlain, M; Johnson, MP; Kelly, G | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
2 other study(ies) available for 3,5-dihydroxyphenylglycine and corticosterone
Article | Year |
---|---|
Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Amino Acids; Animals; Benzoates; Bridged Bicyclo Compounds; Corticosterone; Cycloleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Male; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Phenylacetates; Propionates; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Xanthenes | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |